Non-Small Cell Lung Cancer: Avastin Trends in Use

August 2007

Deliverable: Summary and Tabular Results of Quantitative Data

Objective: To understand current practices and trends in the treatment of non-small cell lung cancer with Avastin, including treatment dose and duration of treatment, by conducting a survey of oncologists.  Specifically:

§         Determine current levels of Avastin use compared to hypothetical maximums

§         Quantify usage of current treatment regimens at various stages of treatment

o        Specific drug combinations

o        Durations of treatment

o        Variations among stages

§         Understand key barriers and drivers of Avastin use

Products Highlighted:

Topics:

§         NSCLC

§         Chemotherapy

§         Anti-angiogenesis

§         Current and future Avastin dosing behavior

§         Avastin regimen duration

§         Expectations around Erbitux and other EGFR inhibitors

§         Expectations of future share between treatment algorithms.